The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Hyperphosphatemia is a common complication of end-stage renal disease and particularly
affects haemodialysis patients. Elevated serum phosphorus contributes to the development of
secondary hyperparathyroidism, Mineral bone disorders,metastatic calcifications and calcific
uremic arteriolopathy. There is a significant association between hyperphosphatemia and
increased morbidity and mortality in end stage renal disease patients including
cardiovascular morbidity and mortality ,also it's associated with hospitalization of
haemodialysis patients.